Form 4: Aspira Women's Health President Acquires 20,000 Restricted Stock Units

Sandra Milligan, President of Aspira Women's Health Inc., reports the acquisition of 20,000 restricted stock units (RSUs) on October 28, 2024.

Summary

• On October 28, 2024, Sandra Milligan, President of Aspira Women's Health Inc., acquired 20,000 restricted stock units.
• These RSUs will vest 100% on December 31, 2024, contingent upon her continued service to the company.
• Each RSU represents a contingent right to receive one share of Aspira Women's Health Inc.'s common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects standard executive compensation practices, indicating confidence in the executive's continued service and contribution to the company's success.

Positives

• The grant of RSUs to a key executive like the President can be seen as an incentive to align her interests with the long-term success of the company.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the RSUs.

Industry Context

This type of equity compensation is common in the healthcare industry to incentivize executives and align their interests with shareholders.

Comparison to Industry Standards

• Granting restricted stock units (RSUs) to executives is a common practice across various industries, including healthcare.
• Companies like Myriad Genetics and Exact Sciences also utilize RSUs as part of their executive compensation packages.
• The vesting schedule and the number of RSUs granted are typically determined based on the executive's role, performance, and industry benchmarks.

Stakeholder Impact

• Shareholders may view this as a positive incentive for the President to drive company performance.
• Employees may see this as a sign of the company's commitment to its leadership.

Key Dates

Keywords

Restricted Stock Units, Form 4, Beneficial Ownership, Aspira Women's Health, Sandra Milligan, Executive Compensation